Position in RCKT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,929,490
-$3,553,580 QoQ
Shares Held
1,097,623
-48.5% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,506,832,621 across 316 Biotechnology names. RCKT ranks #113 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in RCKT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,929,490 | 1,097,623 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,483,070 | 2,131,929 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,247,563 | 1,609,682 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,227,132 | 1,725,360 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $517,154 | 41,142 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $402,941 | 21,816 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $497,149 | 23,091 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,041,215 | 150,008 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,639,832 | 254,916 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,120,986 | 396,339 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $876,267 | 44,100 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,505,759 | 146,279 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,408,061 | 71,950 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,410,424 | 338,999 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,012,917 | 218,962 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,880,149 | 244,650 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,416,328 | 248,114 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,213,383 | 207,875 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,465,921 | 168,569 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $14,699,159 | 331,286 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,674,843 | 103,480 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $331,630 | 14,507 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $481,096 | 22,986 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||